These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 22053888)

  • 1. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor microenvironment: part 1.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving radioresponse through modification of the tumor immunological microenvironment.
    Chi KH; Wang YS; Kao SJ
    Cancer Biother Radiopharm; 2012 Feb; 27(1):6-11. PubMed ID: 22239431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment.
    Shirota H; Klinman DM
    Immunotherapy; 2013 Aug; 5(8):787-9. PubMed ID: 23902544
    [No Abstract]   [Full Text] [Related]  

  • 8. Interventions that induce modifications in the tumor microenvironment.
    Bernhard EJ
    Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemopreventive agents targeting tumor microenvironment.
    Sharma SH; Thulasingam S; Nagarajan S
    Life Sci; 2016 Jan; 145():74-84. PubMed ID: 26679106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy and radiation.
    Hiniker SM; Knox SJ
    Semin Oncol; 2014 Dec; 41(6):702-13. PubMed ID: 25499631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
    Anari F; Ramamurthy C; Zibelman M
    Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to improve the immunogenicity of chemotherapy and radiotherapy.
    Ma Y; Conforti R; Aymeric L; Locher C; Kepp O; Kroemer G; Zitvogel L
    Cancer Metastasis Rev; 2011 Mar; 30(1):71-82. PubMed ID: 21298323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
    Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
    Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
    Ngambenjawong C; Gustafson HH; Pun SH
    Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in targeting tumor microenvironment for immunotherapy.
    Wang L; Zhang L; Zhang Z; Wu P; Zhang Y; Chen X
    Front Immunol; 2024; 15():1472772. PubMed ID: 39421736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
    Harper J; Sainson RC
    Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells.
    Kim SJ; Ha GH; Kim SH; Kang CD
    Immunol Invest; 2014; 43(6):517-34. PubMed ID: 24295450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
    Bader JE; Voss K; Rathmell JC
    Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.